Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y019157 | IM / LA |
The donor was administered the CAPVAXIVE immunization by one of Nurse on 05/23/2025 at 11:50am IM in the donors left arm. The donor stayed with the Nurse to be assessed for any adverse post immunization reactions related to the vaccination administered. During and after that indicated 30 minutes time frame the donor did not have an immediate adverse reaction to the CAPVAXIVE immunization and the donor left the center in good condition. The donor stated that she had common adverse reaction symptoms related to the CAPVAXIVE vaccination starting on 05/24/2025 at 10:40am that occurred until 05/27/2025. These symptoms reported included injection site pain, erythema, and swelling, dizziness, fatigue, headache, nausea, chills, irritability, weakness, tachycardia, shortness of breath, and an itchy rash over the whole body. When asked about treatments the donor stated she did not seek medical treatment as she did not know if she was having all of these symptoms from the reaction or if she was having a panic attack. Also, the donor stated that they haven't had a reaction to any vaccination that she is aware of. The donor reported these symptoms to the nurse at the center on 05/28/2025 and stated that today she was feeling much better and that these common adverse reaction symptoms have subsided. The donor was instructed to seek medical treatment if these symptoms persist and or return and was advised to report this adverse reaction to VAERS. The donor left the center on 05/28/2025 in good condition.
No
No
No
No
N/A